For unlimited access to Class Notes, a Class+ subscription is required.
The EGF Receptor
•RTK family of cell surface receptors
•Includes epidermal growth factor receptor (EGFR/Erb1/Her1) and its relatives
•Receptors of EGFR subgroup essential for embryonic development and adult tissue
homeostasis in vertebrates and invertebrates.
Abnormal activation associated with a variety of cancers.
EGFR overexpression in several human tumors.
Prognostic significance of EGFR overexpression in selected cancers: Poor prognosis, low
survival, high risk of metastases
PI3KAkt cell cycle progression or survival
Non-small-cell lung cancer (NSCLC)
•Leading cause of cancer-related mortality
o15% 5 year survival rate
•EGFR expressed in most NSCLCs pathophysiological implication as a biomaker
Gefitinib – Iressa
•Small molecule TKI of EGFR for treatment of NSCLC
Trials in NSCLC
Treat advanced NSCLC with prior chemotherapy prescription
Not a great response rate
•Gefitinib + Chemo
oNo difference in survival or time to progression
No difference, but subgroup analysis shoed survival benfit in never-
smokers and Asians – significant difference
•Only a small proportion of patients with NSCLC shows dramatic responses to
•Factors that favor Gefitinib sensitivity
Charactersistcs of patients with NSCLC that respond to Gefitinib: